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LETTER TO THE EDITOR 
A NEW ENZYME IN THE PIGMENT PATHWAY? 
To the Editor: 
The paper "Dopachrome Oxidoreductase: A New Enzyme in the 
Pigment Pathway" by Barber et al (83:145-149, 1984) extends initial 
work from our group which showed that the conversion of dopachrome 
to 5,6-dihyd.roxyindole (DHI) and of DHI into melanin is under regu-
latory control in mouse melanomas and in skin of newborn mice 
[1- 4]. Barber et al provide new evidence that the factor(s) regulating 
these steps are proteins. They also show that the activities are present 
in humans as well as in mice. Their findings indicate that regulation 
of melanogenesis at intermediates "distal" to tyrosine and dopa is 
under enzymatic control and is probably a general phenomenon in 
mammals. 
From the data presented, however, it is premature to assign the 
name "dopachrome oxidoreductase" to these activities. My reasons are 
the following: 
1. The measurements were carried out on a crude extract of the cells, 
and there is no demonstration that a single protein, purified to 
homogeneity, contains both "dopachrome conversion factor" and 
"indole blocking factor" activities [2]. 
2. Indole blocking activity was not measured quantitatively, and in 
the physical-chemical characterizations, there were no side-by-
side measurements of the two activities. 
3. There was no characterization of the products formed. The activ-
ities were assessed by measuring the disappearance of absorbance 
at 475 nm, which is an assay only of the conversion of dopachrome 
into a colorless compound. 
Therefore, it has not been ruled out that the reactions in question 
are catalyzed by separate enzymes. Until the activities have been 
purified, and until the reactions have been characterized regarding such 
parameters as product identification and cofactor requirements, both 
the mechanism of action and the number of enzymes involved remain 
open questions. 
John M. Pawelek, Ph.D. 
Yale University School of Medicine 
New Haven, Connecticut 
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Dr. Pawelek has raised several important points regarding our work 
on dopachrome metabolism. We share his concern regarding the name 
of the enzyme and the steps that are catalytically controlled. Dr. 
Pawelek and his group have shown that a factor from melanocytes 
increases the conversion of red dopachrome to a colorless compound, 
and we have shown that this factor is a protein with characteristics of 
an enzyme. In the formation of melanin, dopachrome is converted to 
5,6-dihyd.roxyindole with 5,6-dihyd.roxyindole-2-carboxylic acid an in-
termediate in this conversion [1,2] . S. Pavel has now shown that the 
decarboxylation is pH dependent and spontaneous and does not require 
the catalytic action of an enzyme [3]. This suggests that dopachrome 
oxidoreductase (DCOR) may act at the dopachrome to 5,6-dihyd.rox-
yindole-2-carboxylic step, but, as Dr. Pawelek notes, we did not identify 
the product of the reaction. We suggested the name of dopachrome 
oxidoreductase after review of the recommendations of the Commission 
in Biochemical Nomenclature on the nomenclature and classification 
of enzymes [ 4]. At this point, the name is ·not specific, and may well 
have to be adjusted after purification of the protein and demonstration 
of the specific step that is catalyzed. 
Dr. Pawelek also raises the point that there may be more than one 
enzyme active in this part of the pathway. Our enzyme preparation 
was a crude homogenate and could very well contain other active 
enzymes which may be involved in the melanin pathway. We feel that 
tyrosinase is not involved in the reaction we observed, but further 
discussion of this point must await a purified enzyme preparation. 
Dr. Pawelek has provided a salient insight into the metabolism of 
melanin, and continues to inquire of the exact nature of these reactions. 
His Jetter is appropriate, and a stimulus for us to continue to define 
the specific steps involved in the formation of melanin. 
Joan I. Barber, Ph.D. 
De Wayne Townsend, Ph.D. 
David P. Olds, M.S. 
Richard A. King, M.D., Ph.D. 
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